Skip to main content
. 2006 May 9;94(11):1604–1609. doi: 10.1038/sj.bjc.6603141

Table 2. Worst grade of toxicity for the 41 patients.

  Grade
  1
2
3
4
Toxicity Patients % Patients % Patients % Patients %
Anaemia 7 17 4 10 1 2 0  
Thrombocytopenia 2 5 0   0   0  
Neutropenia 12 29 4 10 6 15 14 34
Nausea 8 20 4 10 0   0  
Vomiting 5 12 2 5 0   0  
Stomatitis 2 5 2 5 0   0  
Diarrhoea 9 22 5 12 4 10 0  
Mucositis 7 17 2 5 0   0  
Pain 1 2 0   0   0  
Fever 2 5 5 12 0   0  
Hypersensitivitya 0   0   3 7 0  
Neuropathy 6 15 1 2 0   0  
Acne-like rash 4 10 3 7 2 5 0  
Asthenia 6 15 4 10 2 5 0  
Increase in transaminases 6 15 3 7 2 5 0  
a

Hypersensitivity reactions after few minutes of starting the first intravenous injection of docetaxel were observed in three patients, which, therefore, were never treated with gefitinib and which were switched to a chemotherapy regimen without docetaxel. Toxicities were recorded according to the National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 2.0.